Evidence map›Paper›PMID 28411238›Full record

ArticleThe Journal of biological chemistry2017

Characterization of protein complexes of the endoplasmic reticulum-associated degradation E3 ubiquitin ligase Hrd1.

Jiwon Hwang, Christopher P Walczak, Thomas A Shaler, James A Olzmann, Lichao Zhang, Joshua E Elias, Ron R Kopito

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Competition between Der1 and ERAD-M substrates controls Hrd1 complex function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  3. The Ubiquitin-Proteasome System in Brain Disorders: Pathogenic Pathways, Post-Translational Tweaks, and Therapeutic Frontiers.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Review
  4. Article
  5. Article
  6. SEL1L-HRD1-mediated ERAD in mammals.Nature cell biology · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Endoplasmic Reticulum-Associated Protein Degradation.Cold Spring Harbor perspectives in biology · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jiwon HwangFrom the Departments of Biology and.
Christopher P WalczakFrom the Departments of Biology and.
Thomas A ShalerSRI International, Menlo Park, California 04025.
James A OlzmannFrom the Departments of Biology and.
Lichao ZhangChemical and Systems Biology, Stanford University, Stanford, California 94305 and.
Joshua E EliasChemical and Systems Biology, Stanford University, Stanford, California 94305 and.
Ron R KopitoFrom the Departments of Biology and kopito@stanford.edu.
Stanford University · USMenlo School · US

Funding

The Ubiquitin Proteasome System in Quality ControlR01GM074874 · NIGMS · STANFORD UNIVERSITY · PI KOPITO, RON R · 2006 to 2022
$8.0M
Elucidating the architecture of native multiprotein complexes involved in ER-associated degradationF32GM113378 · NIGMS · STANFORD UNIVERSITY · PI WALCZAK, CHRISTOPHER PAUL · 2015 to 2017
$168k
NIGMS NIH HHS F32 GM113378NIGMS NIH HHS R01 GM074874
6 · The paper itself

Abstract

Hrd1 is the core structural component of a large endoplasmic reticulum membrane-embedded protein complex that coordinates the destruction of folding-defective proteins in the early secretory pathway. Defining the composition, dynamics, and ultimately, the structure of the Hrd1 complex is a crucial step in understanding the molecular basis of glycoprotein quality control but has been hampered by the lack of suitable techniques to interrogate this complex under native conditions. In this study we used genome editing to generate clonal HEK293 (Hrd1.KI) cells harboring a homozygous insertion of a small tandem affinity tag knocked into the endogenous Hrd1 locus. We found that steady-state levels of tagged Hrd1 in these cells are indistinguishable from those of Hrd1 in unmodified cells and that the tagged variant is functional in supporting the degradation of well characterized luminal and membrane substrates. Analysis of detergent-solubilized Hrd1.KI cells indicates that the composition and stoichiometry of Hrd1 complexes are strongly influenced by Hrd1 expression levels. Analysis of affinity-captured Hrd1 complexes from these cells by size-exclusion chromatography, immunodepletion, and absolute quantification mass spectrometry identified two major high-molecular-mass complexes with distinct sets of interacting proteins and variable stoichiometries, suggesting a hitherto unrecognized heterogeneity in the functional units of Hrd1-mediated protein degradation.

Indexed as

ProteolysisEndoplasmic ReticulumGene Expression Regulation, EnzymologicHEK293 CellsHumansMultiprotein ComplexesUbiquitin-Protein LigasesMultiprotein ComplexesSYVN1 protein, humanUbiquitin-Protein LigasesE3 ubiquitin ligaseendoplasmic-reticulum-associated protein degradation (ERAD)endoplasmic reticulum (ER)Hrd1ubiquitinubiquitin ligase

Identifiers

PMID28411238
PMCPMC5454095
OpenAlexW2606324094

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.